Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Abnormalities”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03578341
What this trial is testing

Oral Colostrum and Its Effect on Immune System

Who this might be right for
Immune System DiseasesPremature Infant DiseaseImmunoglobulin Deficiency
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 96
Not applicableUnknownNCT00951886
What this trial is testing

The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally

Who this might be right for
Ataxia Telangiectasia
Sheba Medical Center 28
Large-scale testing (Phase 3)Study completedNCT00002070
What this trial is testing

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Schering-Plough
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Study completedNCT06631170
What this trial is testing

Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 354
Testing effectiveness (Phase 2)Study completedNCT04352595
What this trial is testing

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Tianjin Hemay Pharmaceutical Co., Ltd 148
Post-approval studies (Phase 4)Ended earlyNCT03389893
What this trial is testing

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT02193698
What this trial is testing

Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

Who this might be right for
POEMS Syndrome
Chiba University 5
Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Large-scale testing (Phase 3)Study completedNCT05511922
What this trial is testing

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 11
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Early research (Phase 1)Study completedNCT05803902
What this trial is testing

An Evaluation of 9MW1911 Injection in Healthy Subjects

Who this might be right for
AsthmaCOPDAtopic Dermatitis
Mabwell (Shanghai) Bioscience Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Large-scale testing (Phase 3)Study completedNCT05372653
What this trial is testing

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Pharmaceutical Co., Ltd. 41
Post-approval studies (Phase 4)UnknownNCT02525172
What this trial is testing

Immune Modulation Therapy for Pompe Disease

Who this might be right for
Pompe Disease
National Taiwan University Hospital 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT01821781
What this trial is testing

Immune Disorder HSCT Protocol

Who this might be right for
Immune Deficiency DisordersSevere Combined ImmunodeficiencyChronic Granulomatous Disease+11 more
Washington University School of Medicine 20
Not applicableStudy completedNCT04180644
What this trial is testing

Skin Tape Transcriptome Methods in Children

Who this might be right for
Atopic Dermatitis
National Jewish Health 20
Large-scale testing (Phase 3)Study completedNCT00035334
What this trial is testing

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Who this might be right for
Secondary (AA) AmyloidosisRheumatoid ArthritisNephrotic Syndrome+3 more
Bellus Health Inc. - a GSK company 150
Not applicableStudy completedNCT06687512
What this trial is testing

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.

Who this might be right for
Atopic Dermatitis
NovoBliss Research Pvt Ltd 44
Next Page